bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.06.15.732328

Dynamic suspension culture enhances scalable maturation of hiPSC-derived cartilage organoids for regenerative medicine

Abstract

BackgroundCartilage tissue engineering requires scalable culture strategies to produce high-quality organoids. Human induced pluripotent stem cells (hiPSCs) provide a renewable source of chondrogenic cells. However, conventional static 3D culture limits tissue maturation, reproducibility, and scalability. Dynamic culture systems may help overcome these limitations, although their application for hiPSC-derived cartilage maturation remains poorly explored. MethodsIn this study, we established and validated a dynamic suspension bioreactor culture platform (CERO, OLS) for scalable maturation of hiPSC-derived chondroprogenitor cells (hiCPCs) into cartilage organoids populated by biomimetic human induced chondrocytes (hiCHOs). Key culture parameters, including aggregate preparation strategy, agitation speed, and maturation duration, were systematically evaluated. Cartilage maturation under dynamic and conventional static culture conditions was assessed by histology and immunohistochemistry, biochemical assays, organoid size measurements, and gene expression (RT-qPCR). In addition, the functional integration of optimized organoids was evaluated in a human osteochondral explant model. ResultsPre-formed manually picked hiCPC aggregates showed improved cartilage formation compared with single-cell seeding or pelleted aggregates in the bioreactor. Dynamic suspension culture promoted increased construct growth, enhanced ECM deposition, and a more favourable cartilage-associated molecular phenotype compared with static culture. HiCHO organoids matured under dynamic suspension conditions displayed increased sulphated glycosaminoglycan and proteoglycan deposition together with higher expression of cartilage-associated genes ACAN, COMP, MGP, and COL2A1. Although prolonged static maturation alone supported continued cartilage development, introducing dynamic suspension culture during later maturation stages further reinforced favourable molecular and matrix-associated features. Importantly, hiCHO organoids generated under optimized dynamic culture conditions successfully filled human cartilage defects and established matrix continuity with surrounding native tissue in a human osteochondral ex vivo explant model. ConclusionsThis study shows that dynamic suspension culture is an effective and scalable strategy for maturation of hiPSC-derived cartilage organoids. Consequently, this approach supports reproducible neo-cartilage production and allows functional testing in human tissue models. These findings support the use of dynamic culture systems for cartilage repair and in vitro/ex vivo cartilage research.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mazzini, G., Houtman, E., Hoolwerff, M., Janssen, M., Kieltyka, R., Sayedipour, S., Hajmousa, G., Mahdad, R., Ramos, Y., Meulenbelt, I.. 2026-06-19. Dynamic suspension culture enhances scalable maturation of hiPSC-derived cartilage organoids for regenerative medicine. https://doi.org/10.64898/2026.06.15.732328

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence targeting re-enables injury-responsive repair in a human RPE aging model

Aging is associated with progressive tissue dysfunction and impaired repair after injury. In the retinal pigment epithelium (RPE), these changes contribute to age-related macular degeneration (AMD), yet the mechanisms limiting repair remain incompletely understood. Here, we establish a longitudinal human embryonic stem cell (hESC)-derived RPE aging model that recapitulates key features of aged human donor RPE and combine it with mosaic cell ablation to assess injury-responsive repair. Although aged RPE cells initiate DNA synthesis after injury, they exhibit impaired mitotic progression, uncoupling S-phase entry from epithelial repopulation. Transcriptomic profiling links this defect to a senescence-associated program marked by inflammatory signaling and suppressed mitotic networks. Pharmacologic reduction of senescent cells with Navitoclax shifts aged RPE toward a younger transcriptional profile but does not induce repopulation by itself. Instead, senolytic treatment primes aged RPE for repair, improving epithelial density and homeostatic function only in response to injury, a strategy we term "senolytic priming." These findings establish a human stem-cell-derived platform for investigating age-associated epithelial repair failure and show that aged human RPE retains latent repair capacity that can be re-enabled by targeting cellular senescence.

Cell Biology↗

Bidirectional modulation of aging-associated cellular phenotypes by mitochondrial genome replacement

Mitochondrial dysfunction is a hallmark of cellular aging, but whether age-associated cellular decline can be functionally reversed remains unclear. Here, we applied mitochondrial genome replacement to replicative senescent fibroblasts and aged T cells derived from mice and humans. In senescent fibroblasts, replacement with mitochondria from young cells extended proliferative lifespan, whereas replacement with aged mitochondria accelerated proliferative decline, indicating bidirectional modulation of aging-associated phenotypes. In aged mouse T cells, mitochondrial genome replacement restored proliferative capacity and significantly enhanced antitumor activity following adoptive transfer into tumor-bearing mice. Similarly, mitochondrial genome replacement in aged human T cells enhanced cytokine production and shifted the transcriptomic programs toward a more youthful state. Collectively, these findings identify mitochondrial genetic integrity as a functional regulator of aging-associated cellular states and support the emerging view that mitochondria actively influence cellular aging trajectories.

Cell Biology↗

The MIRO1-BAX Complex Dictates Life and Death at the Mitochondrial Gate

BAX macropores in the outer mitochondrial membrane (OMM) are canonical mediators of apoptosis, but whether the same pore structure can drive distinct cell death pathways remains unclear. Here, we identify the OMM protein MIRO1 as a context-specific modulator of BAX activity. Mechanistically, MIRO1 binds BAX via MIRO1s N-terminal domain to promote macropore formation and the release of mitochondrial DNA (mtDNA) into the cytoplasm, triggering the STING-pIRF3 signaling axis. In glioma cells, this pathway sustains GPX4 expression via pIRF3-mediated transcriptional activation and confers ferroptosis resistance while bypassing inflammation. By contrast, in Parkinsonian neurons, the MIRO1-BAX complex promotes mitochondrial-stress-induced apoptosis. Using structure-guided drug discovery, we developed first-in-class small molecules that allosterically disrupt the MIRO1-BAX complex by engaging MIRO1s distal GTPase pocket. These compounds sensitize glioma cells to ferroptosis and protect neurons from apoptosis. Our findings reveal a disease-specific mitochondrial switch for life-death decisions and illuminate the molecular logic by which cells exploit and interpret OMM permeabilization.

Cell Biology↗